1. New Products

New Products

Cat. No. Product Name Target Research Area Added Chemical Structure
HY-10448A Capsaicin (purity>99%)

TRP Channel; Autophagy; Apoptosis

Cancer;

Inflammation/Immunology;

Neurological Disease

2021-07 Capsaicin (purity>99%)
HY-B2130A Uric acid sodium

Reactive Oxygen Species; Endogenous Metabolite

Metabolic Disease

2021-07 Uric acid sodium
HY-P1317A Nociceptin (1-13), amide TFA

Opioid Receptor

Neurological Disease

2021-07 Nociceptin (1-13), amide TFA
HY-17559 Actinomycin D

DNA/RNA Synthesis; Autophagy; Bacterial; Apoptosis; Antibiotic

Cancer;

Infection

2021-07 Actinomycin D
HY-12959 Repinotan

5-HT Receptor

Neurological Disease

2021-07 Repinotan
HY-101000 Clazuril

Parasite

Infection

2021-07 Clazuril
HY-128758A DYRKs-IN-1 hydrochloride

DYRK

Cancer

2021-07 DYRKs-IN-1 hydrochloride
HY-18832 AWL-II-38.3

Others

Cancer

2021-07 AWL-II-38.3
HY-130344 SKF83959

Dopamine Receptor

Neurological Disease

2021-07 SKF83959
HY-14286S Levosimendan D3

Potassium Channel; Phosphodiesterase (PDE); Autophagy

Cardiovascular Disease

2021-07 Levosimendan D3
HY-12713 Lisuride

Dopamine Receptor

Neurological Disease

2021-07 Lisuride
HY-134982 Thalidomide-piperazine-Boc

E3 Ligase Ligand-Linker Conjugate

Cancer

2021-07 Thalidomide-piperazine-Boc
HY-10195 Ruboxistaurin

PKC

Metabolic Disease

2021-07 Ruboxistaurin
HY-112368 PHPS1

Phosphatase

Cancer;

Cardiovascular Disease

2021-07 PHPS1
HY-103066 Br-PBTC

nAChR

Neurological Disease

2021-07 Br-PBTC
HY-N9397 Quercetin 3-O-(6''-O-malonyl)-β-D-glucoside

Others

Metabolic Disease

2021-07 Quercetin 3-O-(6''-O-malonyl)-β-D-glucoside
HY-N9400 Lucidenic acid F

Others

Cancer;

Inflammation/Immunology

2021-07 Lucidenic acid F
HY-12206A Thioperamide maleate

Histamine Receptor

Neurological Disease

2021-07 Thioperamide maleate
HY-P0107A RC-3095 TFA

Bombesin Receptor

Inflammation/Immunology

2021-07 RC-3095 TFA
HY-101292 FK614

PPAR

Metabolic Disease

2021-07 FK614